The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zorina O.A.

GBOU VPO "Pervyĭ MGMU imeni I.M. Sechenova"

Boriskina O.A.

Federal'noe gosudarstvennoe biudzhetnoe uchrezhdenie "Tsentral'nyĭ nauchno-issledovatel'skiĭ institut stomatologii i cheliustno-litsevoĭ khirurgii" Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii, Moskva

Leonovich O.A.

Institut poliomielita i virusnykh éntsefalitov im. M.P. Chumakova RAMN

Rebrikov D.V.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia

Genetic factors of aggressive periodontitis risk (matrix proteins, matrix proteases and their regulators)

Authors:

Zorina O.A., Boriskina O.A., Leonovich O.A., Rebrikov D.V.

More about the authors

Journal: Stomatology. 2013;92(1): 76‑83

Views: 2505

Downloaded: 37

Download PDF (RU)
Contact the author
Table of contents

GENETIC FACTORS OF AGGRESSIVE PERIODONTITIS RISK (MATRIX PROTEINS, MATRIX PROTEASES AND THEIR REGULATORS)
GENETIC FACTORS OF AGGRESSIVE PERIODONTITIS RISK (MATRIX PROTEINS, MATRIX PROTEASES AND THEIR REGULATORS)

To cite this article:

Zorina OA, Boriskina OA, Leonovich OA, Rebrikov DV. Genetic factors of aggressive periodontitis risk (matrix proteins, matrix proteases and their regulators). Stomatology. 2013;92(1):76‑83. (In Russ.)

Подписка 2025-2 (Stomatology)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Expe­rimental evaluation of the effi­cacy of tissue-engineered constructs in the treatment of limbal stem cell defi­ciency. Russian Annals of Ophthalmology. 2024;(2-2):80-89
Coro­nary microvascular dysfunction in rheumatic diseases — what do we know today?. Russian Journal of Preventive Medi­cine. 2024;(9):138-143
The role of systemic and local immu­nity in the pathogenesis of endo­metriosis of varying degrees of prevalence of the process: a modern view. Russian Journal of Human Reproduction. 2024;(5):6-14
High mobi­lity group protein B1 (HMGB1) and the pote­ntial for inflammation amplification in preeclampsia and threatened preterm labor. Russian Journal of Human Reproduction. 2024;(5):82-88
Perioperative prevention of bleeding in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(5):118-124
The rela­tionship between inflammatory markers, fati­gue, and effort-based deci­sion-making in patients at clinical high risk for psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):85-91
Effi­cacy of alpha-glutamyl-tryptophan in the treatment of chro­nic atro­phic gastritis: case series. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):121-128
Neuropeptide Y and inflammatory indi­ces in women after repeated cesa­rean section. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):35-40
Anti­fungal immu­nity in patients with chro­nic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2024;(6):40-45
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80

Keywords:

periodontitis
genetic polymorphism
SNP
collagen
MMP
inflammation

Authors:

Zorina O.A.

GBOU VPO "Pervyĭ MGMU imeni I.M. Sechenova"

Boriskina O.A.

Federal'noe gosudarstvennoe biudzhetnoe uchrezhdenie "Tsentral'nyĭ nauchno-issledovatel'skiĭ institut stomatologii i cheliustno-litsevoĭ khirurgii" Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii, Moskva

Leonovich O.A.

Institut poliomielita i virusnykh éntsefalitov im. M.P. Chumakova RAMN

Rebrikov D.V.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia

List of references:

  1. Gemonov V.V., Lavrova E.N., Falin L.I. Razvitie i stroenie organov rotovoi polosti i zubov. GOU VUNMTs MZ RF 2002; 257.
  2. Grudyanov A.I. Zabolevaniya parodonta. M: Med inform agent 2009; 328.
  3. Zorina O.A., Kulakov A.A., Boriskina O.A., Rebrikov D.V. Vzaimosvyaz' polimorfizmov genov MMP2 i MMP9 s razvitiem zabolevanii parodonta. Palliativnaya meditsina i reabilitatsiya 2011; 2: 49-52.
  4. Zorina O.A., Boriskina O.A., Rebrikov D.V. Vzaimosvyaz' geneticheskikh polimorfizmov kollagena tipa COL1A1, COL2A1 i COL3A1 s tipichnymi formami parodontita. Meditsina i kachestvo zhizni 2011; 2: 33-34.
  5. Ivanov V.S. Zabolevaniya parodonta. M: Meditsina 1989.
  6. Klisho E.V., Kondakova I.V., Choinzonov E.L. i dr. Prognosticheskaya znachimost' proteaz u bol'nykh ploskokletochnymi kartsinomami golovy i shei. Byulleten' SO RAMN 2005; 2: 116: 82-91.
  7. Kulakov A.A., Zorina O.A., Boriskina O.A. Geneticheskie faktory v razvitii zabolevanii parodonta. Ros stomat zhurn 2011; 1: 48-51.
  8. Rogova L.N., Shesternina N.V., Zamechnik T.V, Fastova I.A. Matriksnye metalloproteinazy, ikh rol' v fiziologicheskikh i patologicheskikh protsessakh (obzor) vestnik novykh meditsinskikh tekhnologii 2011; KhVIII: 2: 86.
  9. Solov'eva N.I. Matriksnye metalloproteinazy: regulyatsiya aktivnosti i rol' v protsesse onkogeneza. Struktura i funktsii proteoliticheskikh fermentov: materialy konferentsii, 11-13 okt. 2000, Moskva. M 2000.
  10. Solov'eva N.I. Bioorganicheskaya khimiya 1998; 24: 4: 245-255.
  11. Solov'eva N.I. Matriksnye metalloproteinazy: regulyatsiya aktivnosti i rol' v protsesse onkogeneza. Vopr med khimii 2000; 5: 30-31.
  12. Troshin I.Yu., Gromova O.A. Kardiologiya 2008; 10: 14-21.
  13. Khasigov P.Z., Podobed O.V. Biokhimiya 2001; 66: 2: 167-179.
  14. Ahokas K., Lohi J., Illman S.A., Llano E., Elomaa O., Impola U., Karjalainen-Lindsberg M.L., Saarialho-Kere U. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up regulated by transforming growth factor-beta1 in keratinocytes. Lab Invest 2003; 83: 12: 1887-1899.
  15. Aimes R.T., Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the speciFIc3/4- and 1/4-length fragments. J Biol Chem 1995; 270: 11: 5872-5876.
  16. Atici K. et al. Analysis of gingival crevicular fluid intracytoplasmic enzyme activity in patients with adults periodontitis and rapidly progressive periodontitis. A longitudinal study model with periodontal treatment. J Periodontol 1998; 69: 1155-1163.
  17. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002; 115: Pt 19:3719-3727.
  18. Beklen A. et al. Gingival Tissue and Crevicular Fluid Co-operation in Adult Periodontitis. J Dent Res 2006; 85: 1: 59-63.
  19. Bosshardt D.D., Selvig K.A. Dental cementum: the dynamic tissue covering of the root. Periodontol 2000; 1997; 13: 41-75.
  20. Bosshardt D.D. Are cementoblasts a subpopulation of osteoblasts or a unique phenotype? J Dent Res 2005; 84: 390-406.
  21. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim.Biophys. Acta 2000; 1477: 1-2: 267-283.
  22. Castellani C., Malerba G., Sangalli A., Delmarco A., Petrelli E., Rossini M., Assael B.M., Mottes M. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes. J Cyst Fibros 2006; 5: 4: 229-235.
  23. Chiu C.J., Chang M.L., Chiang C.P., Hahn L.J., Hsieh L.L., Chen C.J. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 2002; 11: 7: 646-653.
  24. Chung L., Dinakarpandian D., Yoshida N., Lauer-Fields J.L., Fields G.B., Visse R., Nagase H. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J 2004; 23: 15: 3020-3030.
  25. Cochran D.L., Wozney J.M. Biological mediators for periodontal regeneration. Periodontol 2000; 1999; 19: 40-58.
  26. Cox S.W. et al. Collagen degradation by interleukin 1-stimulated gingival fibroblasts is accomparied by release and activation of multiple matrix metalloproteinases and cysteine proteinases. J Oral Dis 2006; 12: 34-40.
  27. Dahan M. et al. Expression of matrix metalloproteinases in healthy and diseased human gingival. J Clin Periodontol 2001; 28: 128-136.
  28. Di Lullo G.A., Sweeney S.M., Korkko J., Ala-Kokko L., San Antonio J.D. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 2002; 8: 277: 6: 4223-4231.
  29. Dunsmore S.E. et al. Matrilysin expression and function in airway epithelium. J Clin Invest 1998; 102: 1321-1331.
  30. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174.
  31. English W.R., Holtz B., Vogt G., Knäuper V., Murphy G. Characterization of the role of the "MT-loop" - An eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases. J Biol Chem 2001; 276: 45: 42018-42026.
  32. Farrelly N., Lee Y.-J., Oliver J., Dive C., Streuli C.H. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 1999; 144: 1337-1347.
  33. Figueredo C.M. et al. The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 2004; 31: 615-619.
  34. Fini M.E., Cook J.R., Mohan R., Brinckerhoft C.E. In Matrix Metalloproteinases. Eds. Parks W.C., Mecham R.P. Academic Press, San Diego 1998; 299-356.
  35. Hou P., Troen T., Ovejero M.C., Kirkegaard T., Andersen T.L., Byrjalsen I., Ferreras M., Sato T., Shapiro S.D., Foged N.T., Delaisse J.M. Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on theinvolvement of MMPs in bone resorption. Bone 2004; 34: 1: 37-47.
  36. Ingman T. et al. Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 1994; 102: 342-349.
  37. Ingman T. et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996; 23: 1127-1132.
  38. Ingman T. et al. Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. J Oral Microbiol Immunol 1993; 8: 298-305.
  39. Jones S.J. Cement. In: Osborn J.W., editor. Dental anatomy and embryology. Boston: Blackwell Scientific 1981.
  40. Kazushi I., Yasuo Y., Isao N. et al. Matrix metalloproteinase 7 (Matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995; 270: 12: 6691-6697.
  41. Kerkelä E., Bohling T., Herva R., Uria J.A., Saarialho-Kere U. Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation. Bone 2001; 29: 5: 487-493.
  42. Kiili M. et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002; 29: 224-232.
  43. Knäuper V., Will H., López-Otín C., Smith B., Atkinson S.J., Stanton H., Hembry R.M., Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271: 29: 17124-17131.
  44. Kuivaniemi H., Tromp G., Prockop D.J. Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 1997; 9: 4: 300-315.
  45. Kushlinskii N.E., Solovykh E.A., Karaoglanova T.B., Boyar U., Gershtein E.S., Troshin A.A., Maksimovskaya L.N., Yanushevich O.O. Matrix metalloproteinases and inflammatory cytokines in oral fluid of patients with chronic generalized periodontitis and various construction materials. Bull Exp Biol Med 2012; 153: 1: 72-76.
  46. Levin L. Aggressive periodontitis: the silent tooth killer. Alpha Omegan 2011; Fall-Winter: 104: 3-4: 74-78.
  47. Li W., Gibson C.W., Abrams W.R., Andrews D.W., DenBesten P.K. Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta. Matrix Biol 2001; 19: 8: 755-760.
  48. Loesche W.J., Grossman N.S. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 2001; 14: 10: 727-752.
  49. MacNeil R.L., Somerman M.J. Molecular factors regulating development and regeneration of cementum. J Periodontal Res 1993; 28: 550-559.
  50. Maesco G., Bravo M., Bascones F. Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingival. Quintessence Int 2007; 38: 247-252.
  51. Makela M. et al. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 73: 1397-1406.
  52. Michalowicz B.S., Aeppli D., Virag J.G. et al. Periodontal findings in adult twins. Journal of Periodontology 1991; 62: 5: 293-299.
  53. Michalowicz B.S., Diehl S.R., Gunsolley J.C. et al. Evidence of a substantial genetic basis for risk of adult periodontitis. Journal of Periodontology 2000; 71: 11: 1699-1707.
  54. Murphy G., Houbrechts A., Cockett M.I., Williamson R.A., O'Shea M., Docherty A.J.P. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity [published erratum appears in Biochemistry 1991; 30: 42: 10362. Biochemistry 1991; 30: 33: 8097-8102.
  55. Murphy G., McAlpine C.G., Poll C.T., Reynolds J.J. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta 1985; 831: 1: 49-58.
  56. Murphy G., Segain J.P., O'Shea M., Cockett M., Ioannou C., Lefebvre O., Chambon P., Basset P. The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J Biol Chem 1993; 268: 21: 15435-15441.
  57. Nagase H., Woessner J.F. Matrix Metalloproteinases. J Biol Chem 1999; 274: 31: 21491-21494.
  58. Nagase H. In Zinc Metalloproteases in Health and Disease. Eds. Hooper N.M. 1996; 153-204.
  59. Nanci A., Bosshardt D.D. Structure of periodontal tissues in health and disease. Periodontology 2000; 40: 2006: 11-28.
  60. Neiminen A., Nordlund L., Uitto V.J. The effect of treatment on the activity of salivary proteases and glycosidases in adults, with advanced periodontitis. J Periodontol 1993; 64: 297-301.
  61. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 4: 2446-2451.
  62. Patterson M.L., Atkinson S.J., Knäuper V., Murphy G. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 2001; 503: 2-3: 158-162.
  63. Pei D., Weiss S.J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995; 375: 6528: 244-247.
  64. Pendas A.M., Knäuper V., Puente X.S., Llano E., Mattei M.G., Apte S., Murphy G., López-Otín C. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997; 272: 7: 4281-4286.
  65. Pozo P. et al. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. J Periodontal Res 2005; 40: 199-207.
  66. Pun Y.L., Moskowitz R.W., Lie S., Sundstrom W.R., Block S.R., McEwen C., Williams H.J., Bleasel J.F., Holderbaum D., Haqqi T.M. Clinical correlations of osteoarthritis associated with a single-base mutation (Arg519Cys) in type II procollagen gene. A newly defined pathogenesis. Arthritis Rheum 1994; 37: 2: 264-269
  67. Rai B. et al. Biomarkers of periodontitis in oral fluids. J Oral Science 2008; 50: 1: 53-56.
  68. Sadowski T., Dietrich S., Koschinsky F., Ludwig A., Proksch E., Titz B., Sedlacek R. Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Cell Mol Life Sci 2005; 62: 7-8: 870-880.
  69. Sadowski T., Dietrich S., Muller M., Havlickova B., Schunck M., Proksch E., Muller M.S., Sedlacek R. Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation. J Invest Dermatol 2003; 121: 5: 989-996.
  70. Saygin N.E., Giannobile W.V., Somerman M.J. Molecular and cell biology of cementum. Periodontol 2000; 24: 73-98.
  71. Schroeder H.E. Handbook of microscopic anatomy. The periodontium. Berlin: Springer 1986; 5: 23-119.
  72. Sean E. Gill and William C. Parks Metalloproteinases and Their Inhibitors: Regulators of Wound Healing. Int J Biochem Cell Biol 2008; 40: 6-7: 1334-1347.
  73. Seguier S. et al. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue. J Periodontol 2001; 72: 1398-1406.
  74. Shapiro S.D., Robert M.S. Matrix Metalloproteinases Matrix Degradation and More American journal of respiratory cell and molecular biology 1999; 20.
  75. Shipley J.M., Wesselschmidt R.L., Kobayashi D.K., Ley T.J., Shapiro S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA 1996; 93: 9: 3942-3946.
  76. Skoog T., Ahokas K., Orsmark C., Jeskanen L., Isaka K., Saarialho-Kere U. MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture. Exp Dermatol 2006; 15: 10: 775-783.
  77. Stracke J.O., Hutton M., Stewart M., Pendas A.M., Smith B., Lopez-Otin C., Murphy G., Knauper V. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19 - Evidence for a role as a potent basement membrane degrading enzyme. J Biol Chem 2000; 275: 20: 14809-14816.
  78. Suzuki A., Ji G., Numabe Y., Muramatsu M., Gomi K., Kanazashi M., Ogata Y., Shimizu E., Shibukawa Y., Ito A., Ito T., Sugaya A., Arai T., Yamada S., Deguchi S., Kamoi K. Single nucleotide polymorphisms associated with aggressive periodontitis and severe chronic periodontitis in Japanese. Biochem Biophys Res Commun 2004; 317: 3: 887-892.
  79. Teng Y.T., Sodek J., McCulloch C.A. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res 1992; 27: 544-552.
  80. Tervahartiala T. et al. The in vivo expression of the collagenolytic matrix metalloproteinases I/(MMP-2, -8,-13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000; 79: 1969-1977.
  81. Tiiter G. et al. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix of metalloproteinase-3 and tissue inhibitor of metalloproteinase-1. J Clin Periodontol 2005; 32: 1011-1015.
  82. Toledano M., Yamauti M., Osorio E., Osorio R. Bleaching agents increase metalloproteinases-mediated collagen degradation in dentin. J Endod 2011; 37: 12: 1668-1672.
  83. Uitto V.J. et al. Matrilysin (matrix metalloproteinase-7) expression in human junctional epithelium. J Dent Res 2002; 81: 241-246.
  84. Uitto V.J., Overall C.M., McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. J Periodontol 2000; 2003; 31: 77-104.
  85. Van Dyke T.E., Serhan C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82: 2: 82-90.
  86. Vater C.A., Mainardi C.L., Harris E.D. Jr. Inhibitor of human collagenase from cultures of human tendon. J Biol Chem 1979; 254: 8: 3045-3053.
  87. Verstappen J., Von den Hoff. Tissue Inhibitors of Metalloproteinases (TIMPs): Their Biological Functions and Involvement in Oral Disease. J Dent Res 2006; 85: 12: 1074-1084.
  88. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Res 2003; 2: 827-839.
  89. Williamson R.A., Marston F.A.O., Angal S., Koklitis P., Panico M., Morris H.R., Carne A.F., Smith B.J., Harris T.J.R., Freedman R.B. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 1990; 268: 2: 267-274.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.